Research and Development

Showing 15 posts of 9594 posts found.

The weight of evidence – the stories that changed pharma in 2004

January 4, 2005 Research and Development 2004, Vioxx, year in review

Ticking time bombsIn 2004, countries around the world faced up to some home truths about the health of their populations …

Personalised medicine moves a step closer

December 30, 2004 Research and Development, Sales and Marketing

Doctors will be able to use genetic information to determine the best drug dosage for individual patients following approval of …

AstraZeneca looks to Iressa successor after setback

December 16, 2004 Research and Development

AstraZeneca says it is optimistic about two of its most advanced cancer pipeline drugs, which it hopes will  offset a …

Investors unmoved by GSK pipeline news

December 8, 2003 Research and Development

GlaxoSmithKline has presented details of 20 potential blockbusters in its pipeline which it claims could bring it industry leading growth …

Biotech grows up

December 4, 2003 Research and Development, Sales and Marketing alliances, biotech, partnerships, pharma

Sometimes it is hard to see where the fun lies in running a biotechnology company. Discounting the obvious success stories …

HRT – Too great a risk ?

November 4, 2003 Research and Development HRT, clinical trial

The last 15 months have seen the image of HRT change from a miraculous medicine to a risky range of …

Betaferon and Avonex in head-to-head MS trial

October 29, 2003 Research and Development, Sales and Marketing

Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …

Aventis awards ClinPhone preferred supplier status

October 29, 2003 Research and Development

Aventis has made ClinPhone its preferred provider for data management of it clinical trials worldwide.Specialists in telephone and internet-based electronic …

New HRT study shows doubling of cancer risk

October 29, 2003 Research and Development

A new study of over one million UK women has confirmed an increased risk of breast cancer from all forms …

Merck expands into US proteomics

October 29, 2003 Research and Development

Merck KGaA has bought ProtoPlex, a US-based biotech company specialising in functional genomics and proteomics.Privately owned Protoplex will be integrated …

Genzyme buys SangStat for $600m

October 29, 2003 Research and Development

US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment …
The Gateway to Local Adoption Series

Latest content